- Home
- QTRX vs CNTB Comparison
QTRX vs CNTB Comparison
Compare QTRX & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QTRX | CNTB |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.0M | 135.7M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | QTRX | CNTB |
|---|---|---|
| Price | $3.71 | $2.14 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $6.00 | ★ $8.67 |
| AVG Volume (30 Days) | ★ 747.3K | 635.1K |
| Earning Date | 05-06-2026 | 08-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $37,632,000.00 | $64,000.00 |
| Revenue This Year | $25.49 | N/A |
| Revenue Next Year | $10.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 64.52 | N/A |
| 52 Week Low | $2.40 | $1.23 |
| 52 Week High | $8.77 | $3.82 |
Technical Indicators
Market Signals| Indicator | QTRX | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 47.36 | 44.00 |
| Support Level | $3.30 | $2.10 |
| Resistance Level | $3.81 | $2.75 |
| Average True Range (ATR) | 0.32 | 0.22 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 9.37 | 6.76 |
Price Performance
Historical ComparisonAbout QTRX Quanterix Corporation
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.